IL-8 (Protein|Antibody|cDNA Clone|ELISA Kit)

All IL-8 reagents are produced in house and quality controlled, including 7 IL-8 Antibody, 2 IL-8 ELISA, 39 IL-8 Gene, 4 IL-8 Lysate, 8 IL-8 Protein, 1 IL-8 qPCR. All IL-8 reagents are ready to use.

Recombinant IL-8 proteins are expressed by HEK293 Cells, E. coli, Yeast with fusion tags as N-human IgG1-Fc, Native, C-His, N-cleavage.

IL-8 antibodies are validated with different applications, which are ELISA, ELISA(Det), WB, IP, ELISA(Cap).

IL-8 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each IL-8 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

IL-8 ELISA Kit are quality controlled by 8 internation QC standard which guarantee every ELISA Kit with high quality.

IL-8 Protein (8)

Species

IL-8 Protein, Canine, Recombinant

70009-DNAE

Expression host: E. coli

Canine IL-8/Interleukin-8/CXCL8 Protein 12221

IL-8 Protein, Rhesus, Recombinant

90280-CNAE

Expression host: E. coli

Rhesus IL-8/Interleukin-8/CXCL8 Protein 12936

IL-8 Protein, Human, Recombinant (aa 28-99)

10098-HNCH2

Expression host: HEK293 Cells

Human IL-8/Interleukin-8/CXCL8 Protein 8386

IL-8 Protein, Human, Recombinant (aa 28-99)

10098-HNAE

Expression host: E. coli

Human IL-8/Interleukin-8/CXCL8 Protein 8384

IL-8 Protein, Human, Recombinant (His Tag)

10098-H08Y

Expression host: Yeast

Human IL-8/Interleukin-8/CXCL8 Protein 6235

IL-8 Protein, Human, Recombinant (aa 23-99, Fc Tag)

10098-H01H1

Expression host: HEK293 Cells

Human IL-8/Interleukin-8/CXCL8 Protein 8382

IL-8 Protein, Human, Recombinant (aa 23-99)

10098-HNCH1

Expression host: HEK293 Cells

Human IL-8/Interleukin-8/CXCL8 Protein 8385

IL-8 Protein, Human, Recombinant (aa 28-99, Fc Tag)

10098-H01H2

Expression host: HEK293 Cells

Human IL-8/Interleukin-8/CXCL8 Protein 8383
Go

IL-8 Antibody (7)

Application Clonality
Host

Anti-IL-8 Antibody

90280-RP01

Specificity: Rhesus

Application: ELISA

Clonality: PAb

Anti-IL-8 Antibody

10098-MM18

Specificity: Human

Application: ELISA,ELISA(Det)

Clonality: MAb

Anti-IL-8 Antibody

10098-T16

Specificity: Human

Application: ELISA

Clonality: PAb

Anti-IL-8 Antibody

90280-T16

Specificity: Rhesus

Application: ELISA

Clonality: PAb

Anti-IL-8 Antibody

10098-T36

Specificity: Human

Application: WB,IP

Clonality: PAb

Human IL-8 Western blot (WB) 20111

Anti-IL-8 Antibody

10098-MM05

Specificity: Human

Application: ELISA,ELISA(Cap)

Clonality: MAb

Anti-IL-8 Antibody

90280-R009

Specificity: Rhesus

Application: ELISA

Clonality: MAb

Go

IL-8 ELISA KIT & match antibody elias pair set ( 2 )

IL-8 ELISA Kit, Human

KIT10098

Sensitivity: 2.2 pg/mL

Human IL-8/Interleukin-8/CXCL8 ELISA Kit Standard Curve 18765

IL-8 Matched ELISA Antibody Pair Set,Human

SEK10098

Assay Range: 3.91 pg/ml

Human IL-8/Interleukin-8/CXCL8 ELISA Pair Set Standard Curve 18453

IL-8 cDNA Clone (39)

Human
Canine
Rhesus

IL-8 qPCR Primer (1)

IL-8 Lysate (4)

Interleukin 8 (IL-8), also known as CXCL8, which is a chemokine with a defining CXC amino acid motif that was initially characterized for its leukocyte chemotactic activity, is now known to possess tumorigenic and proangiogenic properties as well. This chemokine is secreted by a variety of cell types including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, and various tumor cell lines in response to inflammatory stimuli (IL1, TNF, LPS, etc). In human gliomas, IL-8 is expressed and secreted at high levels both in vitro and in vivo, and recent experiments suggest it is critical to glial tumor neovascularity and progression. Levels of IL-8 correlate with histologic grade in glial neoplasms, and the most malignant form, glioblastoma, shows the highest expression in pseudopalisading cells around necrosis, suggesting that hypoxia/anoxia may stimulate expression. Interleukin (IL)-8/CXCL8 is a potent neutrophil chemotactic factor. Accumulating evidence has demonstrated that various types of cells can produce a large amount of IL-8/CXCL8 in response to a wide variety of stimuli, including proinflammatory cytokines, microbes and their products, and environmental changes such as hypoxia, reperfusion, and hyperoxia. Numerous observations have established IL-8/CXCL8 as a key mediator in neutrophil-mediated acute inflammation due to its potent actions on neutrophils. However, several lines of evidence indicate that IL-8/CXCL8 has a wide range of actions on various types of cells, including lymphocytes, monocytes, endothelial cells, and fibroblasts, besides neutrophils. The discovery of these biological functions suggests that IL-8/CXCL8 has crucial roles in various pathological conditions such as chronic inflammation and cancer. IL-8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer. IL-8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.
Protein
Antibody
ELISA
Gene
qPCR
Lysate
Close